Frumovitz M, Etchepareborda M, Sun CC, Soliman PT, Eifel PJ, Levenback CF, et al. Primary malignant melanoma of the vagina. Obstet Gynecol. 2010;116(6):1358–65.
Article
PubMed
Google Scholar
Udager AM, Frisch NK, Hong LJ, Stasenko M, Johnston CM, Liu JR, et al. Gynecologic melanomas: a clinicopathologic and molecular analysis. Gynecol Oncol. 2017. https://doi.org/10.1016/j.ygyno.2017.08.023.
D'Angelo SP, Larkin J, Sosman JA, Lebbé C, Brady B, Neyns B, et al. Efficacy and safety of Nivolumab alone or in combination with Ipilimumab in patients with mucosal melanoma: a pooled analysis. J Clin Oncol. 2017;35(2):226–35.
Article
PubMed
CAS
Google Scholar
Tsubamoto H, Ueda T, Inoue K, Sakata K, Shibahara H, Sonoda T. Repurposing itraconazole as an anticancer agent. Oncol Lett. 2017;14(2):1240–6.
Article
PubMed
PubMed Central
Google Scholar
Rudin CM, Brahmer JR, Juergens RA, Hann CL, Ettinger DS, Sebree R, et al. Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer. J Thorac Oncol. 2013;8(5):619–23.
Article
PubMed
PubMed Central
CAS
Google Scholar
Antonarakis ES, Heath EI, Smith DC, Rathkopf D, Blackford AL, Danila DC, et al. Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer. Oncologist. 2013;18(2):163–73.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kim DJ, Kim J, Spaunhurst K, Montoya J, Khodosh R, Chandra K, et al. Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma. J Clin Oncol. 2014;32(8):745–51.
Article
PubMed
CAS
Google Scholar
Tsubamoto H, Sonoda T, Yamasaki M, Inoue K. Impact of combination chemotherapy with itraconazole on survival of patients with refractory ovarian cancer. Anticancer Res. 2014;34(5):2481–7.
PubMed
CAS
Google Scholar
Tsubamoto H, Sonoda T, Inoue K. Impact of itraconazole on the survival of heavily pre-treated patients with triple-negative breast cancer. Anticancer Res. 2014;34(7):3839–44.
PubMed
CAS
Google Scholar
Tsubamoto H, Sonoda T, Ikuta S, Tani S, Inoue K, Yamanaka N. Combination chemotherapy with itraconazole for treating metastatic pancreatic cancer in the second-line or additional setting. Anticancer Res. 2015;35(7):4191–6.
PubMed
CAS
Google Scholar
Tsubamoto H, Sonoda T, Ikuta S, Tani S, Inoue K, Yamanaka N. Impact of itraconazole after first-line chemotherapy on survival of patients with metastatic biliary tract cancer. Anticancer Res. 2015;35(9):4923–7.
PubMed
CAS
Google Scholar
Liang G, Liu M, Wang Q, Shen Y, Mei H, Li D, et al. Itraconazole exerts its anti-melanoma effect by suppressing hedgehog, Wnt, and PI3K/mTOR signaling pathways. Oncotarget. 2017;8(17):28510–25.
Article
PubMed
PubMed Central
Google Scholar
Hou JY, Baptiste C, Hombalegowda RB, Tergas AI, Feldman R, Jones NL, et al. Vulvar and vaginal melanoma: a unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma. Cancer. 2017;123(8):1333–44.
Article
PubMed
CAS
Google Scholar
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–47.
Article
PubMed
CAS
Google Scholar
Desar IM, Mulder SF, Stillebroer AB, van Spronsen DJ, van der Graaf WT, Mulders PF, et al. The reverse side of the victory: flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases. Acta Oncol. 2009;48(6):927–31.
Article
PubMed
Google Scholar
Iacovelli R, Massari F, Albiges L, Loriot Y, Massard C, Fizazi K, et al. Evidence and clinical relevance of tumor flare in patients who discontinue tyrosine kinase inhibitors for treatment of metastatic renal cell carcinoma. Eur Urol. 2015;68(1):154–60.
Article
PubMed
Google Scholar
Ugurel S, Rappl G, Tilgen W, Reinhold U. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J Clin Oncol. 2001;19(2):577–83.
Article
PubMed
CAS
Google Scholar
Warso MA, Maniotis AJ, Chen X, Majumdar D, Patel MK, Shilkaitis A, et al. Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma. Clin Cancer Res. 2001;7(3):473–7.
PubMed
CAS
Google Scholar
De Giorgi V, Grazzini M, Benemei S, Marchionni N, Botteri E, Pennacchioli E, et al. Propranolol for off-label treatment of patients with melanoma: results from a cohort study. JAMA Oncol. 2017. https://doi.org/10.1001/jamaoncol.2017.2908.
Gupta A, Unadkat JD, Mao Q. Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP). J Pharm Sci. 2007;96(12):3226–35.
Article
PubMed
CAS
Google Scholar
Zhou L, Yang K, Andl T, Wickett RR, Zhang Y. Perspective of targeting Cancer-associated fibroblasts in melanoma. J Cancer. 2015;6(8):717–26.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ziani L, Safta-Saadoun TB, Gourbeix J, Cavalcanti A, Robert C, Favre G, et al. Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion. Oncotarget. 2017;8(12):19780–94.
Article
PubMed
PubMed Central
Google Scholar
Ueda T, Tsubamoto H, Inoue K, Sakata K, Shibahara H, Sonoda T. Itraconazole modulates hedgehog, WNT/β-catenin, as well as Akt Signalling, and inhibits proliferation of cervical Cancer cells. Anticancer Res. 2017;37(7):3521–6.
PubMed
Google Scholar
Head SA, Shi WQ, Yang EJ, Nacev BA, Hong SY, Pasunooti KK, et al. Simultaneous targeting of NPC1 and VDAC1 by Itraconazole leads to synergistic inhibition of mTOR signaling and angiogenesis. ACS Chem Biol. 2017;12:174–82.
Article
PubMed
CAS
Google Scholar
Contucci AM, Inzitari R, Agostino S, Vitali A, Fiorita A, Cabras T, et al. Statherin levels in saliva of patients with precancerous and cancerous lesions of the oral cavity: a preliminary report. Oral Dis. 2005;11(2):95–9.
Article
PubMed
CAS
Google Scholar
The Human Protein Atlas. https://www.proteinatlas.org/ENSG00000126549-STATH/tissue. Accessed 6 May 2018.
Eisen T, Thomas J, Miller WH Jr, Gore M, Wolter P, Kavan P, et al. Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma. Melanoma Res. 2009;19(3):185–92.
Article
PubMed
CAS
Google Scholar
Plummer R, Lorigan P, Brown E, Zaucha R, Moiseyenko V, Demidov L, et al. Phase I-II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma. Br J Cancer. 2013;109(6):1451–9.
Article
PubMed
PubMed Central
CAS
Google Scholar
Duanmin H, Chao X, Qi Z. eEF1A2 protein expression correlates with lymph node metastasis and decreased survival in pancreatic ductal adenocarcinoma. Hepato-Gastroenterology. 2013;60(124):870–5.
PubMed
CAS
Google Scholar
Greco M, Mitri MD, Chiriacò F, Leo G, Brienza E, Maffia M. Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: association to tumor derived alpha-N-acetylgalactosaminidase activity. Cancer Lett. 2009;283(2):222–9.
Article
PubMed
CAS
Google Scholar
Kozak KR, Su F, Whitelegge JP, Faull K, Reddy S, Farias-Eisner R. Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics. 2005;5(17):4589–96.
Article
PubMed
CAS
Google Scholar
Farias-Eisner G, Su F, Robbins T, Kotlerman J, Reddy S, Farias-Eisner R. Validation of serum biomarkers for detection of early- and late-stage endometrial cancer. Am J Obstet Gynecol. 2010;202(1):73.e1–5.
Article
CAS
Google Scholar
Maciel CM, Junqueira M, Paschoal ME, Kawamura MT, Duarte RL, Carvalho Mda G, et al. Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients. J Exp Ther Oncol. 2005;5(1):31–8.
PubMed
Google Scholar
Lade-Keller J, Riber-Hansen R, Guldberg P, Schmidt H, Hamilton-Dutoit SJ, Steiniche T. E- to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression. Br J Dermatol. 2013;169(3):618–28.
Article
PubMed
CAS
Google Scholar
Ciołczyk-Wierzbicka D, Laidler P. The inhibition of invasion of human melanoma cells through N-cadherin knock-down. Med Oncol. 2018;35(4):42.
Article
PubMed
PubMed Central
CAS
Google Scholar